MEDIAN TECHNOLOGIES (EPA:ALMDT) | Finanzwire

Basculer en Français

10604	Companies
225013	Keywords
153734	Articles
119072	Press releases

Home
Companies
MEDIAN TECHNOLOGIES

PRESS RELEASE

published on 02/11/2026 at 17:45, 4 months 9 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Disclosure of total voting rights and shares as of Jan 31, 2026 by Median Technologies. Cutting-edge AI for cancer diagnoses and treatments. Listed on Euronext Growth market

Voting Rights Shares AI Median Technologies Cancer Diagnoses
BRIEF

published on 02/09/2026 at 07:05, 4 months 11 days ago

Median Technologies receives FDA 510(k) clearance for eyonis® LCS

FDA AI Technology Median Technologies Lung Cancer Screening Eyonis® LCS
BRIEF

published on 02/09/2026 at 07:05, 4 months 11 days ago

FDA Clearance Granted for Median Technologies' AI-based Lung Cancer Device

FDA Clearance AI Technology Lung Cancer Screening Eyonis® LCS Reimbursement Pathway
PRESS RELEASE

published on 02/09/2026 at 07:00, 4 months 11 days ago

Inside Information / Operations of the issuer (acquisitions, sales...)
Median Technologies receives FDA 510(k) clearance for eyonis® LCS, the first AI tech-based detection and diagnosis device for lung cancer screening. The device aims to redefine lung cancer screening with high accuracy and potential to save lives

FDA Clearance AI Technology Median Technologies Eyonis LCS Lung Cancer Screening
BRIEF

published on 01/14/2026 at 17:50, 5 months 6 days ago

Median Technologies: Financial Calendar and Conference Participation in 2026

Investor Conferences Financial Calendar Annual Results Median Technologies AI-powered Medical Imaging
BRIEF

published on 12/03/2025 at 17:50, 6 months 17 days ago

Median Technologies Reveals Voting Rights and Share Capital Structure

Share Capital Voting Rights Regulatory Compliance Financial Transparency Median Technologies
PRESS RELEASE

published on 12/03/2025 at 17:45, 6 months 17 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Median Technologies discloses total voting rights & shares as of Nov 30, 2025, in compliance with French regulations. Company pioneers AI for cancer diagnosis & treatment

Voting Rights Shares French Regulations Median Technologies Cancer Diagnosis
BRIEF

published on 10/21/2025 at 17:50, 7 months 30 days ago

Median Technologies receives €19 million in financing from the EIB

Funding European Investment Bank Median Technologies Cancer Diagnosis Eyonis® LCS
BRIEF

published on 10/13/2025 at 17:50, 8 months 7 days ago

Median Technologies: Documents available for the AGM of October 31, 2025

Shareholders Paris General Assembly Preparatory Documents Median Technologies
BRIEF

published on 08/07/2025 at 17:50, 10 months 13 days ago

MEDIAN TECHNOLOGIES: Voting Rights and Share Capital Update

Share Capital Voting Rights French Regulations Treasury Shares Median Technologies

Accesswire

Published on 06/20/2026 at 01:00, 1 day 4 hours ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 5 hours ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 1 hour ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 4 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 4 hours ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/20/2026 at 21:25, 8 hours 5 minutes ago

VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 23 hours 30 minutes ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 9 hours ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 1 day 10 hours ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 18:29, 1 day 11 hours ago

Designated Person Notification

Les Echos

Published on 06/19/2026 at 19:33, 1 day 9 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 10 hours ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 2 days 11 hours ago

Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 2 days 11 hours ago

EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 2 days 11 hours ago

Statement of transactions in own shares from June 8, 2026 to June 12, 2026

View all LES ECHOS COMFI WIRE